LSE:FEVR (Fevertree Drinks Plc)

About FEVR

Fevertree Drinks PLC is a UK based holding and investment company. The company is engaged in the business activity of developing and marketing premium mixer drinks. Its product portfolio includes Indian tonic water, Mediterranean tonic water, Elderflower tonic water, Aromatic tonic water, Clementine tonic water, Lemon tonic water, Ginger beer, Ginger ale, Smoky ginger ale, Spiced orange ginger ale, Madagascan cola, Sicilian lemonade, Lemonade, Premium Soda Water and Mediterranean Orange. The company operates in the UK, USA, Europe, and other countries, of which most of the revenue is from the United Kingdom.
  • Fevertree Drinks Plc (LSE: FEVR) Latest News

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    2 UK stocks with recovering profit margins

    This writer considers a pair of UK stocks with very different share price trajectories following the pandemic. Would he buy…

    Read more »

    Investing Articles

    After crashing 80% is this former stock market darling the best share to buy today?

    Harvey Jones is looking for the best shares to buy in October and thinks this former growth star could finally…

    Read more »

    The Troat Inn on River Cherwell in Oxford. England
    Investing Articles

    Fevertree shares are down 80% in the FTSE AIM 100! Should I buy them for my ISA?

    Shares of leading mixers maker Fevertree slumped 11% today, leaving this Fool wondering if this might be a golden chance…

    Read more »

    The Troat Inn on River Cherwell in Oxford. England
    Investing Articles

    This unloved UK stock could rise 38%, according to a City broker

    This UK stock has fallen from £30 in 2019 to just £11.50 today. But analysts at Deutsche Bank think it…

    Read more »

    Young Caucasian man making doubtful face at camera
    Investing Articles

    Is this the most overvalued stock on the FTSE AIM?

    As investors, we're constantly trying to steer clear of stocks with unattractive valuations. So should I avoid this FTSE AIM…

    Read more »

    many happy international football fans watching tv
    Investing Articles

    An insider’s buying this AIM stock. Pure genius or misplaced loyalty?

    An insider recently bought shares in the fourth most valuable AIM stock. But I wonder whether a better opportunity lies…

    Read more »

    The Troat Inn on River Cherwell in Oxford. England
    Investing Articles

    Down 59%! Should investors buy Fevertree shares today?

    Fevertree shares have been on a downward trajectory over the last few years. Could now be a good time for…

    Read more »

    Investing Articles

    Fevertree shares are down 65% this year. Is it time to buy?

    Fevertree shares have tanked in 2022. Yet the company continues to grow. Is this a good buying opportunity? Edward Sheldon…

    Read more »

    Investing Articles

    The Fevertree share price is down 70% this year. Has the fizz run out?

    I am on the hunt for low-priced gems. Though the Fevertree share price looks cheap, I believe its growth story…

    Read more »

    Young Caucasian girl showing and pointing up with fingers number three against yellow background
    Investing Articles

    3 growth stocks on my buy list

    As a long-term investor, Paul Summers has been busy compiling a list of growth stocks to buy in these troubled…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    Darktrace share price soars 20% on takeover news! Who could be next?

    Takeover talks are in the air. Our writer considers several potential takeover targets following the Darktrace share price jump.

    Read more »

    Cheerful young businesspeople with laptop working in office
    Investing Articles

    Is now the perfect time to start buying AIM stocks?

    Might it be worth taking on extra risk and buying AIM stocks for the recovery? One of our writers, though…

    Read more »